Join us on January 28th for our 2026 North American Industrial Market Outlook. Register Now!
Sales & Support: +1 800 762 3361
Member Resources
Industrial Info Resources Logo
Global Market Intelligence Constantly Updated Your Trusted Data Source for Industrial & Energy Market Intelligence
Home Page

Advanced Search

Reports related to this article:


Released August 05, 2022 | KOFU, JAPAN
en
Researched by Industrial Info Resources (Sugar Land, Texas)--Major Japanese pharmaceutical companies are producing active pharmaceutical ingredients (API) and/or performing fill-and-finish services at plants that produce COVID-19 vaccines. Projects range from grassroot developments at contract manufacturing organization (CMO) plants, to expansions at a variety of existing plants.

Industrial Info is tracking six capital-spending projects across Japan related to the COVID-19 pandemic, totalling more than US$290 million in investment value. Examples include JCR Pharmaceuticals Company Limited's (Ashiya, Japan) vaccine API plant in Kobe, which is expected to finish construction next spring. Subscribers to Industrial Info's Global Market Intelligence (GMI) Pharma & Biotech Project Database can read more in a detailed project report.

Subscribers can click here for a list of related project reports, and click here for a list of related plant profiles.

Industrial Info Resources (IIR) is the leading provider of industrial market intelligence. Since 1983, IIR has provided comprehensive research, news and analysis on the industrial process, manufacturing and energy related industries. IIR's Global Market Intelligence (GMI) platform helps companies identify and pursue trends across multiple markets with access to real, qualified and validated plant and project opportunities. Across the world, IIR is tracking more than 200,000 current and future projects worth $17.8 trillion (USD).

IIR Logo Globe

Site-wide Scheduled Maintenance for September 27, 2025 from 12 P.M. to 6 P.M. CDT. Expect intermittent web site availability during this time period.

×
×

Contact Us

For More Info!